Question: Pulmonary toxicity is the most important dose limiting side effect of the chemotherapeutic agent bleomycin. What is the most common clinical presentation for patients with bleomycin pulmonary toxicity (BPT)?
Answer: The cited reference notes "Patients with BPT usually present with nonproductive cough, exertional dyspnea, and occasionally fever, and the radiologic findings show bilateral infiltrates." Sleijfer S. Bleomycin-induced pneumonitis. 2001 Chest 120: 617-624 and Hauges HS et al. Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors. 2015 Urol Onc 33(9): 339-406.
Posted in Question Of The Day